Stockysis Logo
  • Login
  • Register
Back to News

Genmab Q1 EPADS $0.083 Misses $0.17 Estimate, Sales $896.000M Beat $890.400M Estimate

Benzinga Newsdesk www.benzinga.com Positive 50.7%
Neg 0% Neu 0% Pos 50.7%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Stockysis © 2026 BISSINT LLC.
Terms of Service Contact Us